시장보고서
상품코드
1867550

액체생검용 채혈관 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

Blood Collection Tubes for Liquid Biopsy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 액체생검용 채혈관 시장 규모는 2024년에 1억 2,000만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 18.6%로 성장하며, 2031년까지 4억 2,600만 달러로 확대할 것으로 예측되고 있습니다.

이 보고서는 최근 액체생검용 채혈관에 대한 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업적 발자취, 자본 배분 패턴, 지역 경제의 상호의존성, 공급망 재구축 등의 관점에서 종합적인 평가를 제공합니다.

액체생검용 채혈관은 세포유리 DNA(cfDNA), 순환종양 DNA(ctDNA), cfRNA, 순환종양세포(CTCs) 등의 순환 바이오마커를 보존하기 위해 전혈 샘플을 채취하고 안정화시키는 것을 목적으로 하는 체외진단용 특수 소모품입니다. 기존 채혈관과 달리, 이들 제품은 채혈 후 세포 용해 및 효소적 분해를 억제하여 비침습적 조기 암 발견, 치료 경과 관찰, 치료 선택에 필수적인 높은 검체 무결성을 보장합니다. 대표적인 유형로는 cfDNA 안정화용 EDTA 튜브와 CTC 포획 튜브가 있으며, 차세대 시퀀싱(NGS), 하이스루풋 PCR, ddPCR(ddPCR) 등의 플랫폼에 대응하고 있습니다.

세계에서 정밀 종양학의 급속한 발전은 액체생검용 채혈 튜브 시장의 주요 촉진요인으로 작용하고 있습니다. 일루미나, 가디언트 헬스, 엑자크트 사이언스 등의 기업 연례 보고서에 따르면 고품질 혈액 샘플에 대한 의존도가 높아지고 있으며, 이에 따라 프리미엄 검체 채취 소모품에 대한 수요가 확대되고 있습니다. 동시에 미국의 'Cancer Moonshot', 중국의 '천현 프로젝트'와 같은 정부 주도의 노력으로 조기 암 검진이 공중 보건 시스템에 통합되고 있으며, 채혈관은 전략적 소모품으로서 그 중요성이 더욱 커지고 있습니다. 만성질환 모니터링, 산전검사, 재택 샘플링과 같은 새로운 이용 사례도 시장 가능성을 확장하고 있습니다.

견고한 성장에도 불구하고 시장은 몇 가지 장벽에 직면해 있습니다. 구체적으로 높은 규제 장벽, 안정성 검증의 장기화, 플랫폼 호환성에 대한 엄격한 요구사항 등을 들 수 있습니다. 바이오셉트와 네타라의 보고서에 따르면 제품은 FDA 및 CE-IVDR 표준을 준수해야 하며, 개발 비용이 증가하고 있습니다. 저가 대체품의 존재는 가격 경쟁을 심화시키고 있습니다. 또한 물류 과정에서의 검체 무결성 유지(특히 콜드체인 요건 하에서의 대응)는 지방 병원 및 원격 채혈 시나리오에서 도입에 있으며, 문제가 되고 있습니다.

액체생검 튜브는 현재 주로 암 검진 및 동반 진단에 사용되고 있으며, 그 적용 범위는 다발성 암 조기 발견(MCED), 미세잔존질환(MRD) 검사, AI를 활용한 진단으로 확대되고 있습니다. 가디언트헬스의 2024년 연례 보고서에는 대규모 바이오뱅크 구축을 위한 병원 및 제약사와의 협력에 대한 내용이 포함되어 있으며, 고객 기반이 학술기관에서 CRO, CDMO, 바이오제약 기업을 포함한 상업적 이용으로 전환되고 있음을 시사하고 있습니다. 재택 검체 채취 및 분산형 진단이 증가함에 따라 업계는 다양한 시장 요구에 대응하기 위해 휴대가 가능하고 상온 보관이 가능한 튜브 설계로 전환하고 있습니다.

이 보고서는 전 세계 액체생검용 채혈관 세계 시장에 대해 총판매량, 판매 매출, 가격, 주요 기업의 시장 점유율 및 순위를 중심으로 지역별, 국가별, 유형별, 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.

이 보고서는 2024년을 기준 연도, 2020-2031년의 과거 데이터와 예측 데이터를 포함하는 액체생검용 채혈관 시장 규모, 추정 및 예측을 판매량(천 단위) 및 매출액(백만 달러)으로 제시하고 있습니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 액체생검용 채혈관 관련 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 지원합니다.

시장 세분화

기업별

  • Roche
  • Streck
  • Preanalytix
  • Norgen Biotek
  • Biocept
  • Qiagen
  • Exact Sciences
  • BD
  • Shengxiang Bio
  • MGI

유형별 부문

  • 플라스틱
  • 유리

용도별 부문

  • 체외진단용
  • 연구 용도

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트
    • 기타 중동 및 아프리카
KSA

자주 묻는 질문

  • 액체생검용 채혈관 시장 규모는 어떻게 예측되나요?
  • 액체생검용 채혈관의 주요 용도는 무엇인가요?
  • 액체생검용 채혈관 시장의 주요 촉진 요인은 무엇인가요?
  • 액체생검용 채혈관 시장의 주요 기업은 어디인가요?
  • 액체생검용 채혈관의 주요 유형은 무엇인가요?
  • 액체생검용 채혈관 시장이 직면한 주요 장벽은 무엇인가요?
  • 액체생검용 채혈관의 새로운 이용 사례는 무엇인가요?

The global market for Blood Collection Tubes for Liquid Biopsy was estimated to be worth US$ 120 million in 2024 and is forecast to a readjusted size of US$ 426 million by 2031 with a CAGR of 18.6% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Blood Collection Tubes for Liquid Biopsy cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Blood Collection Tubes for Liquid Biopsy are specialized in vitro diagnostic consumables designed to collect and stabilize whole blood samples for the preservation of circulating biomarkers such as cell-free DNA (cfDNA), circulating tumor DNA (ctDNA), cfRNA, and circulating tumor cells (CTCs). Unlike conventional blood tubes, these products inhibit cell lysis and enzymatic degradation post-collection, ensuring high sample integrity critical for non-invasive early cancer detection, treatment monitoring, and therapy selection. Common types include cfDNA stabilizing EDTA tubes and CTC capture tubes, which are compatible with platforms like NGS, high-throughput PCR, and droplet digital PCR (ddPCR).

The rapid advancement of global precision oncology is the key driver of the liquid biopsy blood collection tube market. Annual reports from companies such as Illumina, Guardant Health, and Exact Sciences reveal an increasing reliance on high-quality blood samples, boosting demand for premium sample collection consumables. Simultaneously, government initiatives such as the U.S. "Cancer Moonshot" and China's "Thousand Counties Project" are pushing early cancer screening into public health systems, making blood collection tubes strategic consumables. Emerging use cases in chronic disease monitoring, prenatal testing, and at-home sampling are also expanding market potential.

Despite robust growth, the market faces several hurdles including high regulatory barriers, long validation cycles for stability, and strict requirements for platform compatibility. Reports from Biocept and Natera indicate that products must comply with FDA and CE-IVDR standards, increasing development costs. The presence of low-cost alternatives intensifies price-based competition. In addition, maintaining sample integrity during logistics-especially under cold-chain requirements-poses challenges for adoption in rural hospitals and remote sampling scenarios.

Liquid biopsy tubes are currently used primarily in cancer screening and companion diagnostics, but their application is expanding to multi-cancer early detection (MCED), minimal residual disease (MRD) testing, and AI-powered diagnostics. Guardant Health's 2024 annual report notes collaborations with hospitals and pharmaceutical companies to build large-scale biobanks, indicating a shift in customer base from academic to commercial use including CROs, CDMOs, and biopharma firms. With the rise of at-home sampling and decentralized diagnostics, the industry is moving toward portable, ambient-stable tube designs to meet diversified market needs.

This report aims to provide a comprehensive presentation of the global market for Blood Collection Tubes for Liquid Biopsy, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Blood Collection Tubes for Liquid Biopsy by region & country, by Type, and by Application.

The Blood Collection Tubes for Liquid Biopsy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Collection Tubes for Liquid Biopsy.

Market Segmentation

By Company

  • Roche
  • Streck
  • Preanalytix
  • Norgen Biotek
  • Biocept
  • Qiagen
  • Exact Sciences
  • BD
  • Shengxiang Bio
  • MGI

Segment by Type

  • Plastic
  • Glass

Segment by Application

  • IVD
  • Research Use

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Blood Collection Tubes for Liquid Biopsy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Blood Collection Tubes for Liquid Biopsy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Blood Collection Tubes for Liquid Biopsy in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Blood Collection Tubes for Liquid Biopsy Product Introduction
  • 1.2 Global Blood Collection Tubes for Liquid Biopsy Market Size Forecast
    • 1.2.1 Global Blood Collection Tubes for Liquid Biopsy Sales Value (2020-2031)
    • 1.2.2 Global Blood Collection Tubes for Liquid Biopsy Sales Volume (2020-2031)
    • 1.2.3 Global Blood Collection Tubes for Liquid Biopsy Sales Price (2020-2031)
  • 1.3 Blood Collection Tubes for Liquid Biopsy Market Trends & Drivers
    • 1.3.1 Blood Collection Tubes for Liquid Biopsy Industry Trends
    • 1.3.2 Blood Collection Tubes for Liquid Biopsy Market Drivers & Opportunity
    • 1.3.3 Blood Collection Tubes for Liquid Biopsy Market Challenges
    • 1.3.4 Blood Collection Tubes for Liquid Biopsy Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Blood Collection Tubes for Liquid Biopsy Players Revenue Ranking (2024)
  • 2.2 Global Blood Collection Tubes for Liquid Biopsy Revenue by Company (2020-2025)
  • 2.3 Global Blood Collection Tubes for Liquid Biopsy Players Sales Volume Ranking (2024)
  • 2.4 Global Blood Collection Tubes for Liquid Biopsy Sales Volume by Company Players (2020-2025)
  • 2.5 Global Blood Collection Tubes for Liquid Biopsy Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Blood Collection Tubes for Liquid Biopsy Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Blood Collection Tubes for Liquid Biopsy Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Blood Collection Tubes for Liquid Biopsy
  • 2.9 Blood Collection Tubes for Liquid Biopsy Market Competitive Analysis
    • 2.9.1 Blood Collection Tubes for Liquid Biopsy Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Blood Collection Tubes for Liquid Biopsy Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Collection Tubes for Liquid Biopsy as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Plastic
    • 3.1.2 Glass
  • 3.2 Global Blood Collection Tubes for Liquid Biopsy Sales Value by Type
    • 3.2.1 Global Blood Collection Tubes for Liquid Biopsy Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Blood Collection Tubes for Liquid Biopsy Sales Value, by Type (2020-2031)
    • 3.2.3 Global Blood Collection Tubes for Liquid Biopsy Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Blood Collection Tubes for Liquid Biopsy Sales Volume by Type
    • 3.3.1 Global Blood Collection Tubes for Liquid Biopsy Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Blood Collection Tubes for Liquid Biopsy Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Blood Collection Tubes for Liquid Biopsy Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Blood Collection Tubes for Liquid Biopsy Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 IVD
    • 4.1.2 Research Use
  • 4.2 Global Blood Collection Tubes for Liquid Biopsy Sales Value by Application
    • 4.2.1 Global Blood Collection Tubes for Liquid Biopsy Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Blood Collection Tubes for Liquid Biopsy Sales Value, by Application (2020-2031)
    • 4.2.3 Global Blood Collection Tubes for Liquid Biopsy Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Blood Collection Tubes for Liquid Biopsy Sales Volume by Application
    • 4.3.1 Global Blood Collection Tubes for Liquid Biopsy Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Blood Collection Tubes for Liquid Biopsy Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Blood Collection Tubes for Liquid Biopsy Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Blood Collection Tubes for Liquid Biopsy Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Blood Collection Tubes for Liquid Biopsy Sales Value by Region
    • 5.1.1 Global Blood Collection Tubes for Liquid Biopsy Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Blood Collection Tubes for Liquid Biopsy Sales Value by Region (2020-2025)
    • 5.1.3 Global Blood Collection Tubes for Liquid Biopsy Sales Value by Region (2026-2031)
    • 5.1.4 Global Blood Collection Tubes for Liquid Biopsy Sales Value by Region (%), (2020-2031)
  • 5.2 Global Blood Collection Tubes for Liquid Biopsy Sales Volume by Region
    • 5.2.1 Global Blood Collection Tubes for Liquid Biopsy Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Blood Collection Tubes for Liquid Biopsy Sales Volume by Region (2020-2025)
    • 5.2.3 Global Blood Collection Tubes for Liquid Biopsy Sales Volume by Region (2026-2031)
    • 5.2.4 Global Blood Collection Tubes for Liquid Biopsy Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Blood Collection Tubes for Liquid Biopsy Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 5.4.2 North America Blood Collection Tubes for Liquid Biopsy Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 5.5.2 Europe Blood Collection Tubes for Liquid Biopsy Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Blood Collection Tubes for Liquid Biopsy Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 5.7.2 South America Blood Collection Tubes for Liquid Biopsy Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Blood Collection Tubes for Liquid Biopsy Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Blood Collection Tubes for Liquid Biopsy Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Blood Collection Tubes for Liquid Biopsy Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Blood Collection Tubes for Liquid Biopsy Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 6.3.2 United States Blood Collection Tubes for Liquid Biopsy Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Blood Collection Tubes for Liquid Biopsy Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 6.4.2 Europe Blood Collection Tubes for Liquid Biopsy Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Blood Collection Tubes for Liquid Biopsy Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 6.5.2 China Blood Collection Tubes for Liquid Biopsy Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Blood Collection Tubes for Liquid Biopsy Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 6.6.2 Japan Blood Collection Tubes for Liquid Biopsy Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Blood Collection Tubes for Liquid Biopsy Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 6.7.2 South Korea Blood Collection Tubes for Liquid Biopsy Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Blood Collection Tubes for Liquid Biopsy Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Blood Collection Tubes for Liquid Biopsy Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Blood Collection Tubes for Liquid Biopsy Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Blood Collection Tubes for Liquid Biopsy Sales Value, 2020-2031
    • 6.9.2 India Blood Collection Tubes for Liquid Biopsy Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Blood Collection Tubes for Liquid Biopsy Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Roche
    • 7.1.1 Roche Company Information
    • 7.1.2 Roche Introduction and Business Overview
    • 7.1.3 Roche Blood Collection Tubes for Liquid Biopsy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Roche Blood Collection Tubes for Liquid Biopsy Product Offerings
    • 7.1.5 Roche Recent Development
  • 7.2 Streck
    • 7.2.1 Streck Company Information
    • 7.2.2 Streck Introduction and Business Overview
    • 7.2.3 Streck Blood Collection Tubes for Liquid Biopsy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Streck Blood Collection Tubes for Liquid Biopsy Product Offerings
    • 7.2.5 Streck Recent Development
  • 7.3 Preanalytix
    • 7.3.1 Preanalytix Company Information
    • 7.3.2 Preanalytix Introduction and Business Overview
    • 7.3.3 Preanalytix Blood Collection Tubes for Liquid Biopsy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Preanalytix Blood Collection Tubes for Liquid Biopsy Product Offerings
    • 7.3.5 Preanalytix Recent Development
  • 7.4 Norgen Biotek
    • 7.4.1 Norgen Biotek Company Information
    • 7.4.2 Norgen Biotek Introduction and Business Overview
    • 7.4.3 Norgen Biotek Blood Collection Tubes for Liquid Biopsy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Norgen Biotek Blood Collection Tubes for Liquid Biopsy Product Offerings
    • 7.4.5 Norgen Biotek Recent Development
  • 7.5 Biocept
    • 7.5.1 Biocept Company Information
    • 7.5.2 Biocept Introduction and Business Overview
    • 7.5.3 Biocept Blood Collection Tubes for Liquid Biopsy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Biocept Blood Collection Tubes for Liquid Biopsy Product Offerings
    • 7.5.5 Biocept Recent Development
  • 7.6 Qiagen
    • 7.6.1 Qiagen Company Information
    • 7.6.2 Qiagen Introduction and Business Overview
    • 7.6.3 Qiagen Blood Collection Tubes for Liquid Biopsy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Qiagen Blood Collection Tubes for Liquid Biopsy Product Offerings
    • 7.6.5 Qiagen Recent Development
  • 7.7 Exact Sciences
    • 7.7.1 Exact Sciences Company Information
    • 7.7.2 Exact Sciences Introduction and Business Overview
    • 7.7.3 Exact Sciences Blood Collection Tubes for Liquid Biopsy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Exact Sciences Blood Collection Tubes for Liquid Biopsy Product Offerings
    • 7.7.5 Exact Sciences Recent Development
  • 7.8 BD
    • 7.8.1 BD Company Information
    • 7.8.2 BD Introduction and Business Overview
    • 7.8.3 BD Blood Collection Tubes for Liquid Biopsy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 BD Blood Collection Tubes for Liquid Biopsy Product Offerings
    • 7.8.5 BD Recent Development
  • 7.9 Shengxiang Bio
    • 7.9.1 Shengxiang Bio Company Information
    • 7.9.2 Shengxiang Bio Introduction and Business Overview
    • 7.9.3 Shengxiang Bio Blood Collection Tubes for Liquid Biopsy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Shengxiang Bio Blood Collection Tubes for Liquid Biopsy Product Offerings
    • 7.9.5 Shengxiang Bio Recent Development
  • 7.10 MGI
    • 7.10.1 MGI Company Information
    • 7.10.2 MGI Introduction and Business Overview
    • 7.10.3 MGI Blood Collection Tubes for Liquid Biopsy Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 MGI Blood Collection Tubes for Liquid Biopsy Product Offerings
    • 7.10.5 MGI Recent Development

8 Industry Chain Analysis

  • 8.1 Blood Collection Tubes for Liquid Biopsy Industrial Chain
  • 8.2 Blood Collection Tubes for Liquid Biopsy Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Blood Collection Tubes for Liquid Biopsy Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Blood Collection Tubes for Liquid Biopsy Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제